from DealZone:

Deals wrap: Takeda offers $12 billion for rival Nycomed

May 12, 2011

Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed for more than $12 billion, said sources with direct knowledge of the matter. Japan's largest drugmaker is seeking to boost its presence in Europe and emerging markets, as well, the acquisition would help them gain a lung disease drug from Nycomed which has just been approved in the U.S. Japanese drugmakers have been actively pursuing acquisitions to boost growth as they face the loss of patent protection on key medicines.

from DealZone:

Deals wrap: Icahn turns inward

March 8, 2011

Investor Carl Icahn speaks at the Wall Street Journal Deals & Deal Makers conference, held at the New York Stock Exchange, June 27, 2007.  REUTERS/Chip East Seems billionaire investor Carl Icahn has had enough of managing money for outsiders. The 75-year-old stock picker dropped a bit of surprising news on Tuesday when he said he plans on returning all of his clients' money, making him the latest in a string of investors to do so.

from DealZone:

Deals wrap: Galleon trial to be a “battle royal”

March 4, 2011

Raj Rajaratnam, the principal in the $21 million Galleon Group hedge-fund insider trading case, leaves Manhattan Federal Court for a bail hearing on conspiracy and securities fraud charges in New York, January 12, 2010.  REUTERS/Shannon Stapleton The insider trading case against Galleon Group hedge fund founder Raj Rajaratnam finally goes to trial next week. Rajaratnam faces up to 25 years in prison if convicted of conspiracy and securities fraud but plans to fight the charges and clear his name in court.

from Financial Regulatory Forum:

Why U.S. inside traders escape harsh sentences

January 7, 2011

US Courthouse, New YorkBy Andrew Longstreth

NEW YORK, Jan 6 (Reuters Legal) - The recent flurry of insider-trading arrests by the Manhattan U.S. Attorney has set Wall Street on edge. But if recent history is any guide, people found guilty of that crime tend to get off relatively easy, a Reuters Legal analysis suggests.

from Financial Regulatory Forum:

Lessons from Galleon

May 10, 2010

In the prosecution of Galleon Group, the SEC and the Justice Department have charged the principals of the hedge fund with receiving inside information. Court documents reveal a pattern of self-destruction at the firm, according to Marianne M. Jennings, professor of legal and ethical studies at the WP Carey School of Business at Arizona State University, writing in Thomson Reuters Checkpoint's WG&L Accounting & Compliance Alert.

from Breakingviews:

Still on the hunt for a big hedgie

November 6, 2009

The biggest insider trading prosecution in two decades still would not be more than a one- or two-day story if it wasn't for the criminal charges against hedge fund titan Raj Rajaratnam.

from Financial Regulatory Forum:

U.S. SEC says insider-trading may be a “business model” for some hedge funds

November 6, 2009

Robert Khuzami, director of Enforcement at the Securities Exchange Commission, speaks at a news conference in Washington, June 19, 2009.    REUTERS/Joshua Roberts    (UNITED STATES CRIME LAW BUSINESS)   By Jonathan Stempel and Rachelle Younglai
NEW YORK, Nov 6 (Reuters) - A top U.S. securities regulator said some funds may now view insider trading as a central tenet of their business models, rather than as a one-time opportunity for big rewards as sometimes happened in the 1980s.

from Financial Regulatory Forum:

New arrests in Galleon insider-trading case

November 5, 2009

NEW YORK, Nov 5 (Reuters) - Nine more people have been arrested in the Galleon Group insider-trading scandal, bringing to 15 the number charged in the biggest hedge fund-related case in history.

from Breakingviews:

The missing pieces in Galleon’s puzzle

November 4, 2009

Think of the Galleon Management insider trading case as a puzzle with several pieces left to be snapped into place by federal authorities.

from Breakingviews:

Bear is the securities case worth watching

October 29, 2009

The financial world remains abuzz over the latest twist and turns in the insider-trading case involving Galleon Management co-founder Raj Rajaratnam. At the same time, too little attention is being paid to the criminal trial of two former Bear Stearns hedge fund managers.